Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

63.57
+1.352.17%
Post-market: 63.40-0.1689-0.27%19:42 EDT
Volume:11.27K
Turnover:710.22K
Market Cap:95.65M
PE:- -
High:63.76
Open:62.31
Low:62.22
Close:62.22
52wk High:68.00
52wk Low:36.13
Shares:1.50M
Float Shares:1.50M
Volume Ratio:0.23
T/O Rate:0.75%
Dividend:0.65
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Trading DAY-Oil, Yields Slide

Reuters
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Aug 26

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.
·
Aug 26

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

Circio bolsters board as it advances circular RNA gene therapy platform

TIPRANKS
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

TIPRANKS
·
Aug 25

Binance launches 5 stock perpetuals with 20x leverage

cryptonews
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25